Product cited in:
Esteghamati, Khandan, Momeni, Behdadnia, Ghajar, Nikdad, Noshad, Nakhjavani, Afarideh: "Circulating levels of fibroblast growth factor 21 in early-stage diabetic kidney disease." in: Irish journal of medical science, Vol. 186, Issue 3, pp. 785-794, 2018 (PubMed).
Chen, Zhao, Wan, Ran, Qin, Wang, Gao, Shu, Zhang, Liu, Zhang, Zhu, Mi: "Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial." in: Pharmacological research : the official journal of the Italian Pharmacological Society, Vol. 99, pp. 74-81, 2015 (PubMed).
Qin, Zhou, Chen, Zhao, Ran, Zeng, Wu, Chen, Kang, Shu, Zhang, Mi et al.: "Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with ..." in: PLoS ONE, Vol. 10, Issue 7, pp. e0133496, 2015 (PubMed).
Dong, Shi, Xu, Cai: "Increased Plasma S100A12 Levels Are Associated With Diabetic Retinopathy and Prognostic Biomarkers of Macrovascular Events in Type 2 Diabetic Patients." in: Investigative ophthalmology & visual science, Vol. 56, Issue 8, pp. 4177-85, 2015 (PubMed).